Programs
· 1:1 practitioner-led care · All necessary supplies included · MD-designed protocols · Medication shipped discreetly to your door · 1:1 practitioner-led care · All necessary supplies included · MD-designed protocols · Medication shipped discreetly to your door
(386) 999-9999
Schedule
Lab
Disclaimer: This treatment is available by prescription only through a licensed healthcare provider. A comprehensive evaluation, including a cardiovascular health assessment and medical history, is required prior to initiating treatment. PT-141 can affect blood pressure and heart rate; therefore, ongoing monitoring and follow-up are required throughout the program. This treatment is not appropriate for all patients and is subject to provider discretion.
  • Transform With

PT-141 (Bremelanotide) (Injection)

Investigational melanocortin peptide administered via subcutaneous injection that may support central libido signaling and sexual arousal pathways in structured wellness protocols.

How It Feels

  • A noticeable rise in sexual “interest signal” within a few hours
  • Increased mental focus on intimacy and physical connection
  • Heightened responsiveness to stimulation and arousal cues
  • A strong, time-bound window of enhanced desire and readiness

Four Rules for Success

  • Use only within a clinician-supervised protocol
  • Time use strategically 2-4 hours prior to intended activity
  • Do not exceed recommended monthly frequency limits
  • Avoid stacking with other CNS-active agents unless guided
Book Your Consultation
PROVIDER-SUPPORTED PROGRAMS
MEDICATION SHIPPED DISCREETLY TO YOUR DOOR
1:1 PRACTITIONER-LED CARE
ALL NECESSARY SUPPLIES ALWAYS FREE
BEST MEDICATION PRICES
PROVIDER-SUPPORTED PROGRAMS
MEDICATION SHIPPED DISCREETLY TO YOUR DOOR
1:1 PRACTITIONER-LED CARE
ALL NECESSARY SUPPLIES ALWAYS FREE
BEST MEDICATION PRICES

The Science Behind PT-141

PT-141 (bremelanotide) is a melanocortin receptor agonist that acts primarily on MC3R and MC4R pathways in the hypothalamus, influencing central nervous system signalling related to sexual desire and reward processing rather than vascular mechanisms.

Usage & Dosage

  • Subcutaneous injection (abdomen)
  • Administer 2–4 hours prior to anticipated activity
  • Effects typically last 24–72 hours per cycle window
  • Do not exceed clinician-defined monthly frequency
  • Individual response timing may vary
Book Your Consultation
Disclaimer: This treatment is available by prescription only through a licensed healthcare provider. A comprehensive evaluation, including a cardiovascular health assessment and medical history, is required prior to initiating treatment. PT-141 can affect blood pressure and heart rate; therefore, ongoing monitoring and follow-up are required throughout the program. This treatment is not appropriate for all patients and is subject to provider discretion.